qppv

pSintetica, based in Mendrisio, Switzerland, seeks a Pharmacovigilance Project Manager and Deputy QPPV to support oversight, maintenance, and continuous improvement of the global PV system in compliance with Swiss, EU and international regulations. /ppYou will lead PV projects, ensure continuity of PV operations, and oversee safety data handling across...

pFounded in 1921 and headquartered in Mendrisio (Switzerland), Sintetica's mission is to continuously strive to improve therapies by enhancing its products' formulations and usability for the benefit of clinicians and patients. /p pWe do so in close cooperation with clinical experts, who shape our understanding of their unmet needs and drive our efforts to...

Overview The Senior Medical Director, Global Risk Management & Safety Surveillance (GRMSS) will be responsible for developing and ensuring execution of all patient safety risk management activities for molecular entities under clinical development as well as for Incyte marketed products. This will include pharmacovigilance activities and interventions...

Job Descriptionbr/br/pThe Global Quality GVP Manager mission is toensure quality oversight and quality assurance activities related to GVP area and guide and support from a quality perspective the global and local, as applicable, PV activities within Sobi /ppKey responsibilities include in particular: /pulliContribute to the development of the audit strategy...

Head of Medical Safety GCSP page is loaded## Head of Medical Safety GCSPremote type: Hybrid (remote and on-site)locations: Kvistgaard: Berntime type: Full timeposted on: Posted Yesterdayjob requisition id: JR101347At Bavarian Nordic, we are committed to saving and improving lives by unlocking the power of the immune system. Our commercial...

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;...

By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms of Use.  I further attest that all information I submit in my employment application is true to the best of my knowledge.Job...

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;...

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;...

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;...

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate...